Efthymios N. Deliargyris, MD

Efthymios N. Deliargyris, MD

Chief Medical OfficeratCytosorbents· In proxies 2021–2025

Pay in FY2025-18% from the year before · Cytosorbents stock -29.8% the same year

Efthymios N. Deliargyris, MD was paid $663.5K in FY2025 (Dec), down 18%. Cytosorbents stock fell 29.8% that year.

Pay$100 in the stock at the end of FY20 → $8
Pay is from the Summary Compensation Table of each Cytosorbents proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. CytosorbentsPublic company · 5 yr
    • Chief Medical Officer2021 – Present · 5 yrStock in role -97%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?